Evidence map›Paper›PMID 28296588›Full record

Trial reportJournal of medicinal food2017

A Healthy Balance of Plasma Cholesterol by a Novel Annurca Apple-Based Nutraceutical Formulation: Results of a Randomized Trial.

Gian Carlo Tenore, Domenico Caruso, Giuseppe Buonomo, Maria D'Avino, Pietro Campiglia, Luciana Marinelli, Ettore Novellino

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of medicinal food, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 26 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Agri-Food Wastes as Natural Source of Bioactive Antioxidants.Antioxidants (Basel, Switzerland) · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Gian Carlo Tenore1 Department of Pharmacy, University of Naples Federico II , Naples, Italy .
Domenico Caruso2 Department of Internal Medicine, Hospital Cardarelli , Naples, Italy .
Giuseppe Buonomo3 Coop. Samnium Medica , Benevento, Italy .
Maria D'Avino2 Department of Internal Medicine, Hospital Cardarelli , Naples, Italy .
Pietro Campiglia4 Department of Pharmaceutical and Biomedical Sciences, University of Salerno , Salerno, Italy .
Luciana Marinelli1 Department of Pharmacy, University of Naples Federico II , Naples, Italy .
Ettore Novellino1 Department of Pharmacy, University of Naples Federico II , Naples, Italy .
University of Naples Federico II · ITAzienda Ospedaliera G.Rummo · ITUniversity of Salerno · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiovascular diseases are nowadays preferential targets of preventive medicine through a straightforward therapy on lipid profile. However, statins, the first-line lipid-lowering drug therapy, specifically act on low-density lipoprotein cholesterol (LDL-C), having a modest effect on plasma high-density lipoprotein cholesterol (HDL-C) concentrations. Today, a number of novel HDL-targeted therapies are emerging, along with unexpected side effects. Thus, novel and possibly safe substances, able to correct impaired lipid profile in humans, are still in great demand. Herein, based on encouraging clinical data, we formulated a nutraceutical product (AppleMetS

Indexed as

AdolescentAdultAgedAged, 80 and overCardiovascular DiseasesCholesterolDietary SupplementsFemaleHumansHypolipidemic AgentsMaleMalusMiddle AgedPlant ExtractsYoung AdultCholesterolHypolipidemic AgentsPlant ExtractsAnnurca applenutraceuticalplasma cholesterolpolyphenolsrandomized controlled clinical trial

Identifiers

PMID28296588
PMCPMC5361772
OpenAlexW2589215935

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.